Zobrazeno 1 - 10
of 28
pro vyhledávání: '"MG, myasthenia gravis"'
Autor:
Paaladinesh Thavendiranathan, Sonal Gandhi, Bernd J. Wintersperger, Husam Abdel-Qadir, Aaron Izenberg, Davor Brinc, Joyce Chan, Diego H. Delgado, Shiying Liu
Publikováno v:
JACC: CardioOncology
Autor:
Salvatore Benvenga, Alessandro Antonelli, Carmen Bonanno, Poupak Fallahi, Carmelo Rodolico, Fabrizio Guarneri
Publikováno v:
Journal of Clinical & Translational Endocrinology, Vol 26, Iss, Pp 100274-(2021)
Journal of Clinical & Translational Endocrinology
Journal of Clinical & Translational Endocrinology
Highlights • Alpha-enolase, aldehyde reductase-I and dimethylargininase-I are SREAT autoantigens. • Molecular mimicry between thyroid and CNS autoantigens is hypothesized in SREAT. • Homology with TSH-R, Tg and TPO exists for 6, 27 and 47 of 46
Publikováno v:
Neurological sciences (Online) 40 (2019): 195–197. doi:10.1007/s10072-018-3554-4.
info:cnr-pdr/source/autori:Enrica Filippelli 1, Stefania Barone 1, Alfredo Granata 1, Rita Nisticò 2, Paola Valentino 1,2/titolo:A case of facioscapulohumeral muscular dystrophy and myasthenia gravis with positivity of anti-Ach receptor antibody: a fortuitous association?/doi:10.1007%2Fs10072-018-3554-4./rivista:Neurological sciences (Online)/anno:2019/pagina_da:195/pagina_a:197/intervallo_pagine:195–197/volume:40
info:cnr-pdr/source/autori:Enrica Filippelli 1, Stefania Barone 1, Alfredo Granata 1, Rita Nisticò 2, Paola Valentino 1,2/titolo:A case of facioscapulohumeral muscular dystrophy and myasthenia gravis with positivity of anti-Ach receptor antibody: a fortuitous association?/doi:10.1007%2Fs10072-018-3554-4./rivista:Neurological sciences (Online)/anno:2019/pagina_da:195/pagina_a:197/intervallo_pagine:195–197/volume:40
Autor:
Daigo Ueyama, Hajime Kondo, Hidetoshi Akita, Takahiro Yanase, Takahiro Yasui, Yoshinobu Moritoki
Publikováno v:
Urology Case Reports, Vol 34, Iss, Pp 101508-(2021)
Urology Case Reports
Urology Case Reports
Ipilimumab plus nivolumab (Ipi/Nivo) has revolutionized advanced renal cell carcinoma (RCC) treatment. However, it encompassed fatal immune-related adverse events (irAEs). Myocarditis with concomitant myasthenia gravis (MG) has a mortality rate of 50
Autor:
Stephen Jolles, Charlotte Cunningham-Rundles, Peter Kiessling, Hans D. Ochs, Bernhard Greve, Donald C. Vinh, Hans-Hartmut Peter
Publikováno v:
The Journal of Allergy and Clinical Immunology
The neonatal fragment crystallizable (Fc) receptor (FcRn) functions as a recycling mechanism to prevent degradation and extend the half-life of IgG and albumin in the circulation. Several FcRn inhibitors selectively targeting IgG recycling are now mo
Autor:
Koji Iinuma, Takuya Koie, Shigeaki Yokoi, Yuka Muramatsu Maekawa, Manabu Takai, Tomohiro Tsuchiya, Daiki Kato, Keita Nakane
Publikováno v:
Urology Case Reports
Urology Case Reports, Vol 31, Iss, Pp-(2020)
Urology Case Reports, Vol 31, Iss, Pp-(2020)
We report a fatal case of pembrolizumab-induced myasthenia gravis and myocarditis in a patient with metastatic bladder cancer. A 77-year-old man was aware of eye ptosis and diplopia after three weeks from first infusion of pembrolizumab, an anti-prog
Publikováno v:
International Journal of Surgery Case Reports
Highlights • A thymoma mainly occurs in the anterior mediastinum, while few are seen in the middle mediastinum. • This is the first case of a mediastinum thymoma induced severe tracheal compression in literature. • In our review of middle media
Publikováno v:
Urology Case Reports
Urology Case Reports, Vol 29, Iss, Pp-(2020)
Urology Case Reports, Vol 29, Iss, Pp-(2020)
We present a 78-year-old male with renal cell carcinoma who developed myasthenia gravis complicated by myositis after nivolumab administration, which was verified by the presence of antibodies against the acetylcholine receptor. The initial symptom w
Autor:
Kazutoshi Shibuya, Yoko Azuma, Sota Sadamoto, Akira Iyoda, Yoichi Anami, Satoshi Koezuka, Megumi Wakayama, Takashi Makino, Naobumi Tochigi, Hajime Otsuka
Publikováno v:
Journal of Cardiothoracic Surgery
Journal of Cardiothoracic Surgery, Vol 13, Iss 1, Pp 1-4 (2018)
Journal of Cardiothoracic Surgery, Vol 13, Iss 1, Pp 1-4 (2018)
Background Some patients with thymoma present with a very large mass in the thoracic cavity. Although the most effective treatment for thymoma is surgical resection, it is difficult to perform because of the size of the tumor and the infiltration of
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.